{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:34:42Z","timestamp":1648521282801},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.lfs.2014.03.014","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T04:36:26Z","timestamp":1395462986000},"page":"118-126","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia"],"prefix":"10.1016","volume":"102","author":[{"given":"Hao-Yuan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Hsiang","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.03.014_bb0095","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood.V91.5.1700","article-title":"BCR\u2013ABL exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3","volume":"91","author":"Amarante-Mendes","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2014.03.014_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the BCR\/ABL hybrid gene","volume":"233","author":"Ben","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.lfs.2014.03.014_bb0120","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1128\/MCB.15.10.5531","article-title":"Structural and signaling requirements for BCR\u2013ABL-mediated transformation and inhibition of apoptosis","volume":"15","author":"Cortez","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.lfs.2014.03.014_bb0125","first-page":"2589","article-title":"The BCR\u2013ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway","volume":"13","author":"Cortez","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2014.03.014_bb0015","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2014.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.bjc.6602190","article-title":"Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant BCR\u2013ABL expressing cells and decreases AKT phosphorylation","volume":"91","author":"Deutsch","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lfs.2014.03.014_bb0040","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/jm00130a020","article-title":"Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors","volume":"32","author":"Gazit","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.lfs.2014.03.014_bb0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2014.03.014_bb0035","first-page":"517","article-title":"Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833","volume":"7","author":"Jaffrezou","year":"1995","journal-title":"Oncol Res"},{"key":"10.1016\/j.lfs.2014.03.014_bb0130","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1074\/jbc.274.7.3927","article-title":"Protein kinase C iota activity is necessary for BCR\u2013ABL-mediated resistance to drug-induced apoptosis","volume":"274","author":"Jamieson","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2014.03.014_bb0070","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lfs.2014.03.014_bb0065","first-page":"201","article-title":"Signal transduction by wild-type and leukemogenic ABL proteins","volume":"1333","author":"Komatsu","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lfs.2014.03.014_bb0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-138-10-200305200-00010","article-title":"Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics","volume":"138","author":"Kurzrock","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lfs.2014.03.014_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor 1 receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lfs.2014.03.014_bb0020","doi-asserted-by":"crossref","first-page":"33490","DOI":"10.1074\/jbc.M204042200","article-title":"Inhibition of phosphorylation of BAD and Raf-1 by AKT sensitizes human ovarian cancer cells to paclitaxel","volume":"277","author":"Mabuchi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2014.03.014_bb0115","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.1073\/pnas.83.24.9768","article-title":"Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome","volume":"83","author":"Mes-Masson","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2014.03.014_bb0135","doi-asserted-by":"crossref","first-page":"27521","DOI":"10.1074\/jbc.272.44.27521","article-title":"Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis","volume":"272","author":"Murray","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2014.03.014_bb0055","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1021\/bi00068a024","article-title":"The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor","volume":"32","author":"Ohmichi","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2014.03.014_bb0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/endo.138.4.5092","article-title":"Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins","volume":"138","author":"Parrizas","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2014.03.014_bb0025","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2014.03.014_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1054-3589(08)61071-6","article-title":"Role of BCR\u2013ABL kinase in resistance to apoptosis","volume":"41","author":"Samali","year":"1997","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.lfs.2014.03.014_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568011033482378","article-title":"Apoptosis induced by topoisomerase inhibitors","volume":"3","author":"Sordet","year":"2003","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.lfs.2014.03.014_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/mp.54.3.133","article-title":"IGF-I receptor signaling in transformation and differentiation","volume":"54","author":"Valentinis","year":"2001","journal-title":"Mol Pathol"},{"key":"10.1016\/j.lfs.2014.03.014_bb0105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.274.5288.787","article-title":"Suppression of TNF-alpha-induced apoptosis by NF-kappaB","volume":"274","author":"Van Antwerp","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.lfs.2014.03.014_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lfs.2014.03.014_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s002800050989","article-title":"The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review","volume":"44","author":"Wang","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lfs.2014.03.014_bb0050","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1054\/bjoc.2001.2171","article-title":"Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells","volume":"85","author":"Wen","year":"2001","journal-title":"Br J Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T17:34:54Z","timestamp":1597599294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0024320514003397"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.014","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}